vimarsana.com
Home
Live Updates
Drug Use-Related Software Back in the Spotlight at the U.S.
Drug Use-Related Software Back in the Spotlight at the U.S.
Drug Use-Related Software Back in the Spotlight at the U.S. Food and Drug Administration | Wilson Sonsini Goodrich & Rosati
In late September 2023, the U.S. Food and Drug Administration (FDA) released a draft guidance on “Regulatory Considerations for Prescription Drug Use-Related Software.” This guidance...
Related Keywords
Wilson Sonsini Goodrich Rosati ,
Radiological Health ,
Drug Administration ,
Digital Health Technologies ,
Device Software Functions ,
Digital Health Policy ,
Wilson Sonsini Goodrich ,
Prescription Drug Use Related Software ,
Drug Use Related Software ,
Drug Evaluation ,
Biologics Evaluation ,
Digital Health Policy Documents ,
Submission Recommendations ,
Predetermined Change Control Plan ,
Machine Learning ,
Enabled Device Software Functions ,
Digital Health ,
Cosmetic Act ,
Prescribing Information ,